$FBLG
1 catalyst touching FBLG in the last 60 days, newest first, each with the price move that followed.
- 55
FibroBiologics raises $1.02M via convertible debt from Peak One
FibroBiologics issued a $1.2M convertible debenture with a 15% original issue discount (net proceeds $1.02M) and 125,000 restricted shares to Peak One Opportunity Fund. The terms include 0% current interest, convert at $0.78/share only upon default, and mandate 50% of any cash raises over $1.5M go toward repayment, plus restrictions on issuing above a Nasdaq-capped 1.67M shares without stockholder approval. This dilutes existing shareholders and limits future fundraising flexibility, but the small capital raise and defensive conversion mechanics suggest moderate near-term pressure.
FBLG ▼SEC 8-K · 8 Oct 2026, 21:15 UTC
Information only. AURA does not give buy or sell recommendations.